Copyright
©2012 Baishideng Publishing Group Co.
World J Orthop. Nov 18, 2012; 3(11): 175-181
Published online Nov 18, 2012. doi: 10.5312/wjo.v3.i11.175
Published online Nov 18, 2012. doi: 10.5312/wjo.v3.i11.175
Figure 1 Regulation of osteoclast differentiation by osteoblasts through macrophage colony-stimulating factor, receptor activator of nuclear factor-κB ligand, and osteoprotegerin production.
Osteoblasts express two cytokines essential for osteoclast differentiation, macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL). Osteoblasts constitutively express M-CSF. On the other hand, osteoblasts express RANKL as a membrane-associated form in response to bone resorption-stimulating factors such as 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], parathyroid hormone (PTH), prostaglandin E2 (PGE2), and interleukin 11 (IL-11). Osteoclast precursors express c-Fms (M-CSF receptor) and RANK (RANKL receptor) and differentiate into osteoclasts in the presence of M-CSF and RANKL. Osteoblasts also produce osteoprotegerin (OPG), which inhibits osteoclastogenesis by blocking the RANKL-RANK interaction.
- Citation: Yamashita T, Takahashi N, Udagawa N. New roles of osteoblasts involved in osteoclast differentiation. World J Orthop 2012; 3(11): 175-181
- URL: https://www.wjgnet.com/2218-5836/full/v3/i11/175.htm
- DOI: https://dx.doi.org/10.5312/wjo.v3.i11.175